Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Public ClinicalTrials.gov record NCT01724346. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Participated in Study PCYC-1115-CA (Ibrutinib Versus Chlorambucil)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
An Open-label Extension Study in Patients 65 Years or Older with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Participated in Study PCYC-1115-CA (Ibrutinib versus Chlorambucil)
Study identification
- NCT ID
- NCT01724346
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 269 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 3, 2013 (Actual)
- Primary completion
- Aug 18, 2023 (Actual)
- Completion
- Aug 18, 2023 (Actual)
- Last update posted
- Sep 19, 2024
2013 – 2023
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope /ID# 1116-0047 | Duarte | California | 91010 | — |
| Moores Cancer Center at UC San Diego /ID# 1116-0408 | La Jolla | California | 92093 | — |
| Stanford University/Stanford Cancer Center, Campus Drive /ID# 1116-0038 | Stanford | California | 94305 | — |
| University of Chicago /ID# 1116-0126 | Chicago | Illinois | 60637 | — |
| Norton Cancer Institute - St Matthews /ID# 1116-0071 | Louisville | Kentucky | 40207 | — |
| Comprehensive Cancer Centers of Nevada /ID# 1116-0712 | Henderson | Louisiana | 89052 | — |
| University of Massachusetts - Worcester /ID# 1116-0307 | Worcester | Massachusetts | 01655 | — |
| Washington University-School of Medicine /ID# 1116-0221 | St Louis | Missouri | 63110 | — |
| Northwell Health/Long Island Jewish Hospital /ID# 1116-0350 | New Hyde Park | New York | 11042 | — |
| University of Rochester Medical Center /ID# 1116-0127 | Rochester | New York | 14642-0001 | — |
| Southeastern Medical Oncology Center /ID# 1116-0656 | Goldsboro | North Carolina | 27534 | — |
| Kaiser Permanente - Northwest /ID# 1116-0677 | Portland | Oregon | 97227 | — |
| University of Pittsburgh - UPMC (Hillman Cancer Center) /ID# 1116-0050 | Pittsburgh | Pennsylvania | 15232 | — |
| University of Texas MD Anderson Cancer Center /ID# 1116-0032 | Houston | Texas | 77030 | — |
| Oncology of San Antonio /ID# 1116-0653 | San Antonio | Texas | 78240 | — |
| Providence St. Mary Regional Cancer Center /ID# 1116-0731 | Walla Walla | Washington | 99362 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01724346, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 19, 2024 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01724346 live on ClinicalTrials.gov.